All news

Officer Patrick Plewman plans to sell 11,717 Quest Diagnostics (DGX) shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Quest Diagnostics officer Patrick Plewman intends to sell 11,717 common shares of DGX, valued at approximately $3.02 million, with an approximate sale date of November 9, 2026. The shares were acquired through restricted stock vesting and a stock option exercise, with a Rule 10b5-1 plan adopted on August 11, 2026. This transaction is detailed in a Form 144 SEC filing.

Read original source

DGX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.